DEA Scheduling Delays Can Be Reduced With Early Studies, Frequent Sharing

Early interactions with FDA and the Drug Enforcement Administration may help drug sponsors avoid a long lag time between NDA approval and controlled substance scheduling, industry and agency experts said at the Food and Drug Law Institute’s annual meeting.